Replies to post #124 on Kodiak Sciences Inc. (KOD)

[Whalatane]

Congrats. re where we go from here ....Baker Bros control this Co and they usually eventually sell to BP ( Big Pharma )

Baker Bros. Advisors, LP 19.92M Dec 31, 2025 37.55% 701,553,755

Are U also in RZLT ?

Kiwi

[Whalatane]

From Trefis
The Roadmap to a Re-Rate...to $120 a share

The stock's ascent to a commercial multiple will happen sequentially based on three upcoming milestones:

Q3 2026 (The DAYBREAK Readout): Phase 3 data for wet AMD. This is an optionality play. A win adds a second multi-billion-dollar indication and will force immediate analyst upgrades. A miss trims the upside but leaves the Diabetic Retinopathy baseline intact.

Late 2026 (BLA Submission): The formal FDA filing for Zenkuda. This fundamentally de-risks the asset, lowering the discount rate applied to future cash flows.

2027 (FDA Approval & Launch):
The final re-rate. KOD stops trading on trial anxiety and starts trading on revenue visibility.

Risk is a likely capital raise some time in 2026.
I expect the Co to partner or sell to BP ( Big Pharma ) and not try to launch the drug themselves
JMO
Kiwi